Takeo Fujii Selected Research

Takeo Fujii Research Topics

Disease

18	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2015
10	Neoplasms (Cancer) 10/2020 - 08/2003
6	Pathologic Complete Response 01/2020 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
3	Periodontitis 07/2008 - 06/2002
2	Circulating Neoplastic Cells 01/2020 - 01/2017
2	Disease Progression 07/2017 - 11/2016
1	Inflammatory Breast Neoplasms 01/2020
1	Lobular Carcinoma 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Ductal Carcinoma 01/2018
1	Cardiotoxicity 11/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2015
1	Injection Site Reaction 01/2015
1	Rhabdomyolysis 08/2003
1	Periodontal Diseases (Periodontal Disease) 06/2003
1	Periodontal Pocket (Periodontal Pockets) 06/2002
1	Bone Resorption 06/2002

Drug/Important Bio-Agent (IBA)

7	Hormones (Hormone)IBA 10/2020 - 12/2015
4	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2017
3	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2016
3	Androgen Receptors (Androgen Receptor)IBA 09/2017 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 07/2017 - 06/2003
3	AnthracyclinesIBA 12/2015 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2016
2	Biological ProductsIBA 01/2018 - 07/2017
2	Estrogen ReceptorsIBA 01/2017 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 06/2003 - 06/2002
1	Cytotoxins (Cytolysins)IBA 09/2021
1	EnzymesIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	ChromatinIBA 01/2021
1	MTOR InhibitorsIBA 10/2020
1	Capecitabine (Xeloda)FDA Link 10/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Radium-223IBA 01/2020
1	pertuzumabIBA 12/2018
1	Epidermal Growth Factor (EGF)IBA 12/2018
1	Immune Checkpoint InhibitorsIBA 10/2018
1	Cell-Free Nucleic AcidsIBA 07/2017
1	Messenger RNA (mRNA)IBA 07/2017
1	LigandsIBA 07/2017
1	AntibodiesIBA 01/2017
1	Keratins (Keratin)IBA 01/2017
1	DAPIIBA 01/2017
1	Fluoxymesterone (Halotestin)FDA Link 11/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2015
1	PlatinumIBA 12/2015
1	Methotrexate (Mexate)FDA LinkGeneric 12/2015
1	Fluorouracil (Carac)FDA LinkGeneric 12/2015
1	Docetaxel (Taxotere)FDA Link 12/2015
1	taxaneIBA 12/2015
1	Pharmaceutical PreparationsIBA 11/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015
1	Epirubicin (Ellence)FDA LinkGeneric 11/2015
1	liposomal doxorubicin (Doxil)FDA Link 11/2015
1	fosaprepitant FDA Link 01/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2003
1	CytokinesIBA 06/2003
1	Interleukin-8 (Interleukin 8)IBA 06/2003
1	InterleukinsIBA 06/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 06/2003
1	bone resorption factorIBA 06/2002
1	LipopolysaccharidesIBA 06/2002

Therapy/Procedure

10	Therapeutics 09/2021 - 12/2015
7	Neoadjuvant Therapy 01/2020 - 01/2015
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2015
2	Immunotherapy 01/2018 - 01/2018
1	Time-to-Treatment 07/2017
1	Adjuvant Chemotherapy 12/2015
1	Treatment Delay 11/2015
1	Nephrectomy 08/2003
1	Nephroureterectomy 08/2003